These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30187836)

  • 1. Novel Nanoparticles for Tumor Targeting Drug Delivery.
    Gao H
    Curr Drug Metab; 2018; 19(9):722. PubMed ID: 30187836
    [No Abstract]   [Full Text] [Related]  

  • 2. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral drug delivery with nanoparticulate carriers.
    Holback H; Yeo Y
    Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents.
    Bhagat M; Halligan S; Sofou S
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1306-16. PubMed ID: 22201591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
    Choudhury NN; He H
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ligand nanoparticle conjugation approach for targeted cancer therapy.
    Karra N; Benita S
    Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can nano-delivery systems selectively kill cancerous cells?
    Kyriazi ME; Heuer-Jungemann A; Kanaras AG
    Ther Deliv; 2017 Apr; 8(4):171-173. PubMed ID: 28222658
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.
    Amreddy N; Babu A; Muralidharan R; Panneerselvam J; Srivastava A; Ahmed R; Mehta M; Munshi A; Ramesh R
    Adv Cancer Res; 2018; 137():115-170. PubMed ID: 29405974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting for delivery.
    Nat Biomed Eng; 2019 Sep; 3(9):671-672. PubMed ID: 31501568
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual nanoparticle drug delivery: the future of anticancer therapies?
    King MR; Mohamed ZJ
    Nanomedicine (Lond); 2017 Jan; 12(2):95-98. PubMed ID: 27885896
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
    Kumar P; Gulbake A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Image-Guided Drug Delivery: State of the Art.
    Cai W; Chen F
    Curr Drug Targets; 2015; 16(6):526-7. PubMed ID: 26206205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.